최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, v.39 no.8, 2016년, pp.1160 - 1170
Kim, Mi Eun (Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University) , Lee, Joo Yeon (Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University) , Lee, Kyung Moon (Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University) , Park, Hee Ra (Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University) , Lee, Eunjin (Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University) , Lee, Yujeong (Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University) , Lee, Jun Sik (Department of Biology, College of Natural Science, Chosun University) , Lee, Jaewon (Department of Pharmacy, College of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan)
Bee venom (BV), also known as apitoxin, is widely used in traditional oriental medicine to treat immune-related diseases. Recent studies suggest that BV could be beneficial for the treatment of neurodegenerative diseases. Parkinson's disease (PD) is the second most common neurodegenerative disease n...
PLoS One D Alvarez-Fischer 8 e61700 2013 10.1371/journal.pone.0061700 Alvarez-Fischer D, Noelker C, Vulinovic F, Grunewald A, Chevarin C, Klein C, Oertel WH, Hirsch EC, Michel PP, Hartmann A (2013) Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model. PLoS One 8:e61700
Brain Res DW Anderson 905 44 2001 10.1016/S0006-8993(01)02466-0 Anderson DW, Neavin T, Smith JA, Schneider JS (2001) Neuroprotective effects of pramipexole in young and aged MPTP-treated mice. Brain Res 905:44-53
J Neurol Sci JP Bennett Jr 163 25 1999 10.1016/S0022-510X(98)00307-4 Bennett JP Jr, Piercey MF (1999) Pramipexole-a new dopamine agonist for the treatment of Parkinson’s disease. J Neurol Sci 163:25-31
FEBS J F Blandini 279 1156 2012 10.1111/j.1742-4658.2012.08491.x Blandini F, Armentero MT (2012) Animal models of Parkinson’s disease. FEBS J 279:1156-1166
Brain Res Bull CV Borlongan 36 549 1995 10.1016/0361-9230(94)00242-S Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sanberg PR (1995) Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats. Brain Res Bull 36:549-556
Parkinsonism Relat Disord SY Cho 18 948 2012 10.1016/j.parkreldis.2012.04.030 Cho SY, Shim SR, Rhee HY, Park HJ, Jung WS, Moon SK, Park JM, Ko CN, Cho KH, Park SU (2012) Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson’s disease. Parkinsonism Relat Disord 18:948-952
Neurologic Diseases in the Elderly Research Group Neurology MC Rijk De 54 S21 2000 De Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group Neurology 54:S21-S23
Neurol Res AR Doo 32 Suppl 1 88 2010 10.1179/016164109X12537002794282 Doo AR, Kim ST, Kim SN, Moon W, Yin CS, Chae Y, Park HK, Lee H, Park HJ (2010) Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson’s disease. Neurol Res 32(Suppl 1):88-91
Front Neuroanat MT Herrero 9 32 2015 10.3389/fnana.2015.00032 Herrero MT, Estrada C, Maatouk L, Vyas S (2015) Inflammation in Parkinson’s disease: role of glucocorticoids. Front Neuroanat 9:32
Toxicon SJ Hong 46 39 2005 10.1016/j.toxicon.2005.03.015 Hong SJ, Rim GS, Yang HI, Yin CS, Koh HG, Jang MH, Kim CJ, Choe BK, Chung JH (2005) Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon 46:39-45
J Ethnopharmacol HS Jang 99 157 2005 10.1016/j.jep.2005.02.026 Jang HS, Kim SK, Han JB, Ahn HJ, Bae H, Min BI (2005) Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line. J Ethnopharmacol 99:157-160
BMC Biol JN Joyce 2 22 2004 10.1186/1741-7007-2-22 Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D (2004) Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson’s disease, and downregulates the dopamine transporter via the D3 receptor. BMC Biol 2:22
Neurochem Int WK Khalil 80 79 2015 10.1016/j.neuint.2014.11.008 Khalil WK, Assaf N, Elshebiney SA, Salem NA (2015) Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. Neurochem Int 80:79-86
Int J Neurosci JI Kim 121 209 2011 10.3109/00207454.2010.548613 Kim JI, Yang EJ, Lee MS, Kim YS, Huh Y, Cho IH, Kang S, Koh HK (2011) Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson’s disease. Int J Neurosci 121:209-217
Ann N Y Acad Sci IJ Kopin 648 96 1992 10.1111/j.1749-6632.1992.tb24527.x Kopin IJ (1992) Features of the dopaminergic neurotoxin MPTP. Ann N Y Acad Sci 648:96-104
Life Sci YB Kwon 71 191 2002 10.1016/S0024-3205(02)01617-X Kwon YB, Lee HJ, Han HJ, Mar WC, Kang SK, Yoon OB, Beitz AJ, Lee JH (2002) The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci 71:191-204
J Pharmacopuncture SH Lee 15 7 2012 Lee SH, Kwon GS, Kang MS, Yoon HM, Kim CH (2012) Comparative study on the effects of bee venom pharmacopuncture according to the treatment method for knee osteoarthritis. J Pharmacopuncture 15:7-14
Toxins (Basel) SH Lee 7 2835 2015 10.3390/toxins7082835 Lee SH, Choi SM, Yang EJ (2015) Bee venom acupuncture augments anti-inflammation in the peripheral organs of hSOD1G93A transgenic mice. Toxins (Basel) 7:2835-2844
Neurotherapeutics ME Lull 7 354 2010 10.1016/j.nurt.2010.05.014 Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7:354-365
J Pharm Biomed Anal J Matysiak 54 273 2011 10.1016/j.jpba.2010.08.020 Matysiak J, Schmelzer CE, Neubert RH, Kokot ZJ (2011) Characterization of honeybee venom by MALDI-TOF and nanoESI-QqTOF mass spectrometry. J Pharm Biomed Anal 54:273-278
Eur J Pharmacol J Mierau 215 161 1992 10.1016/0014-2999(92)90024-X Mierau J, Schingnitz G (1992) Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Eur J Pharmacol 215:161-170
Neuropharmacology A Mirshafiey 53 353 2007 10.1016/j.neuropharm.2007.05.002 Mirshafiey A (2007) Venom therapy in multiple sclerosis. Neuropharmacology 53:353-361
Int Immunopharmacol DO Moon 7 1092 2007 10.1016/j.intimp.2007.04.005 Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, Lee JD, Choi YH, Kim GY (2007) Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 7:1092-1101
Res Vet Sci HO Nisbet 93 488 2012 10.1016/j.rvsc.2011.08.007 Nisbet HO, Ozak A, Yardimci C, Nisbet C, Yarim M, Bayrak IK, Sirin YS (2012) Evaluation of bee venom and hyaluronic acid in the intra-articular treatment of osteoarthritis in an experimental rabbit model. Res Vet Sci 93:488-493
J Neurol O Rascol 247 Suppl 2 II51 2000 Rascol O (2000) The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson’s disease. J Neurol 247(Suppl 2):II51-II57
Development K Sakurada 126 4017 1999 10.1242/dev.126.18.4017 Sakurada K, Ohshima-Sakurada M, Palmer TD, Gage FH (1999) Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126:4017-4026
Eur J Neurol AH Schapira 9 Suppl 3 7 2002 10.1046/j.1468-1331.9.s3.9.x Schapira AH (2002a) Dopamine agonists and neuroprotection in Parkinson’s disease. Eur J Neurol 9(Suppl 3):7-14
Neurology AH Schapira 58 S9 2002 10.1212/WNL.58.suppl_1.S9 Schapira AH (2002b) Neuroprotection and dopamine agonists. Neurology 58:S9-S18
J Neurochem JY Shin 111 1042 2009 10.1111/j.1471-4159.2009.06381.x Shin JY, Park HJ, Ahn YH, Lee PH (2009) Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson’s disease: a direct comparison study. J Neurochem 111:1042-1050
Toxins (Basel) J Silva 7 3179 2015 10.3390/toxins7083179 Silva J, Monge-Fuentes V, Gomes F, Lopes K, Dos Anjos L, Campos G, Arenas C, Biolchi A, Goncalves J, Galante P, Campos L, Mortari M (2015) Pharmacological alternatives for the treatment of neurodegenerative disorders: wasp and bee venoms and their components as new neuroactive tools. Toxins (Basel) 7:3179-3209
J Rheumatol SD Somerfield 15 1878 1988 Somerfield SD, Brandwein S (1988) Bee venom and adjuvant arthritis. J Rheumatol 15:1878
Pharmacol Ther DJ Son 115 246 2007 10.1016/j.pharmthera.2007.04.004 Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT (2007) Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther 115:246-270
J Neurol Neurosurg Psychiatry Y Stern 46 145 1983 10.1136/jnnp.46.2.145 Stern Y, Mayeux R, Rosen J, Ilson J (1983) Perceptual motor dysfunction in Parkinson’s disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry 46:145-151
Cell Tissue Res P Teismann 318 149 2004 10.1007/s00441-004-0944-0 Teismann P, Schulz JB (2004) Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation. Cell Tissue Res 318:149-161
Adv Protein Chem Struct Biol KU Tufekci 88 69 2012 10.1016/B978-0-12-398314-5.00004-0 Tufekci KU, Meuwissen R, Genc S, Genc K (2012) Inflammation in Parkinson’s disease. Adv Protein Chem Struct Biol 88:69-132
Neuroscientist T Tzounopoulos 9 434 2003 10.1177/1073858403259282 Tzounopoulos T, Stackman R (2003) Enhancing synaptic plasticity and memory: a role for small-conductance Ca2+-activated K+ channels. Neuroscientist 9:434-439
Neurotherapeutics MR Vargas 7 471 2010 10.1016/j.nurt.2010.05.012 Vargas MR, Johnson JA (2010) Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics 7:471-481
Transl Neurodegener Q Wang 4 19 2015 10.1186/s40035-015-0042-0 Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener 4:19
J Neuroinflamm EJ Yang 7 69 2010 10.1186/1742-2094-7-69 Yang EJ, Jiang JH, Lee SM, Yang SC, Hwang HS, Lee MS, Choi SM (2010) Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. J Neuroinflamm 7:69
J Neuroinflamm EJ Yang 8 69 2011 10.1186/1742-2094-8-69 Yang EJ, Kim SH, Yang SC, Lee SM, Choi SM (2011) Melittin restores proteasome function in an animal model of ALS. J Neuroinflamm 8:69
Parkinsonism Relat Disord F Zhang 18 Suppl 1 S213 2012 10.1016/S1353-8020(11)70066-9 Zhang F, Zhou H, Wilson BC, Shi JS, Hong JS, Gao HM (2012) Fluoxetine protects neurons against microglial activation-mediated neurotoxicity. Parkinsonism Relat Disord 18(Suppl 1):S213-S217
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.